🇺🇸 FDA
Patent

US 12194082

Compositions and methods for treatment of homocystinuria

granted A61KA61K2300/00A61K31/198

Quick answer

US patent 12194082 (Compositions and methods for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2300/00, A61K31/198, A61K31/205, A61K31/385